当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2017年第29期
编号:13102826
糖尿病慢性肾脏病早期患者继发性甲状旁腺功能亢进症的影响因素分析(4)
http://www.100md.com 2017年10月15日 《中国医药导报》 2017年第29期
     [16] Uluogullari CA,Balkan F,Caner S,et al. The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus [J]. BMC Endocr Disord,2015,15(29):33.

    [17] Tufan AN,Soyluk O,Tufan F. True vitamin D deficiency with secondary hyperparathyroidism [J]. J Rheumatol,2016, 43(11):2078.

    [18] Levin A,Bakris GL,Molitch M,et al. Prevalence of abnormal serum vitamin D,PTH,calcium and phosphorus in patients with chronic kidney disease:results of the study to evaluate early kidney disease [J]. Kid Intern,2007,71(1):31-38.

    [19] Baldane S,Ipekci SH,Evcen R,et al. A case of hypercalcaemic crisis secondary to coexistence of primary hyperparathyroidism and Graves' disease [J]. Endocr Regul,2016,50(4):225-228.

    [20] Chanchlani R,Ackerman S,Piva E,et al. Intraperitoneal calcitriol for treatment of severe hyperparathyroidism in children with chronic kidney disease:a therapy forgotten [J]. Perit Dial Int,2016,36(6):688-690.

    [21] ■iprová H,Sou■ek M,Fry■ák Z,et al. Symptomatic and asymptomatic primary hyperparathyroidism in outpatient care-current issues [J]. Vnitr Lek,2016,62(10):775-780.

    [22] Fernandes S,Almeida P,Melo-Gomes J,et al. Brown tumors in secondary hyperparathyroidism in a patient with lupus nephritis [J]. J Clin Rheumatol,2016,22(8):438-439.

    (收稿日期:2017-02-21 本文編辑:李亚聪), 百拇医药(杨清柏 纪国新 陈志忠 黄玉平 陈红 张慧敏)
上一页1 2 3 4